Email updates

Keep up to date with the latest news and content from BioPsychoSocial Medicine and BioMed Central.

Open Access Editorial

A neurological approach to biopsychosocial medicine: Lessons from irritable bowel syndrome

Shin Fukudo

Author Affiliations

Department of Behavioral Medicine, Tohoku University Graduate School of Medicine Sendai, Japan

BioPsychoSocial Medicine 2011, 5:1  doi:10.1186/1751-0759-5-1


The electronic version of this article is the complete one and can be found online at: http://www.bpsmedicine.com/content/5/1/1


Received:13 January 2011
Accepted:31 January 2011
Published:31 January 2011

© 2011 Fukudo; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Editorial

Modern people are still influenced by the mind-body dualism of Rene Descartes. Some of these people said "Anxiety aggravated the symptoms of these patients," a notion that most people probably consider natural. By contrast, I would like to criticize this concept because anxiety is posited as an independent driving force that actively changes one's body. However, anxiety per se is a subjective feeling produced by the brain and somatic signals from the body. Actually, neural activities in the central and autonomic nervous systems along with endocrine and immune function change the body. From this point of view, anxiety is not the CAUSE of mind-body changes but the RESULT of them. The origin and synthetic processing of emotion are more important than simple idea that the "mind" directly changes the body. Descartes' mind-body dualism conceals, in our view, how diseases should be recognized and analyzed.

Functional gastrointestinal disorders are useful for illustrating how the rationale of "nervism" of my notion is manifest. In particular, irritable bowel syndrome (IBS) is a prototype of functional gastrointestinal disorders [1], and the biopsychosocial model is well fit to IBS [1]. Although genes, inflammation, gut microbiota, psychosocial stress, and early learning may play an important role in the pathogenesis of IBS [2,3], brain-gut interactions cannot be excluded from the pathophysiology of IBS [4]. Brain imaging studies have clarified the roles of the anterior cingulate cortex, amygdala, insula and the brain stem in response to visceral stimulation [2,5,6]. These structures produce both visceral pain and negative emotion that are typical symptoms of IBS patients. Some researchers interpret the anxiety and depression of IBS patients as "noise" or "confounding factors" that require control. However, IBS patients naturally have negative emotion. Some IBS patients may not have anxiety or depression at the clinically diagnostic level, but a high percentage of IBS patients show increased levels of anxiety and depression. Therefore, the concept that "pure IBS" pathophysiology is completely separated from anxiety and depression is influenced by the Descartes' mind-body dualism and may hinder our ability to see the true nature of the mind-body relationship.

The clinical usefulness of psychological treatments for IBS patients is evidence of the rationale of the biopsychosocial model. The theoretical background of psychotherapies for IBS is as follows. First, IBS patients have deranged life styles characterized by more perceived stress, more irregular sleep and more irregular meals [7]. Reduction of these risk factors is the first step to minimize the exacerbating factors of IBS. Second, the doctor-patient relationship is important for effective treatment. A positive physician-patient interaction is associated with a good prognosis of IBS [8]. Third, the close relationship between daily stress or hassles and IBS symptoms is present [9]. The stress response should be managed. Fourth, IBS patients show high response to placebo [10]. This phenomenon means that suggestion and expectation greatly influence the therapeutic effect. Fifth, IBS patients have high levels of anxiety, depression, and somatization [11]. Not only neuropharmacotherapies but also psychotherapies are indispensable for these co-morbid disorders whose improvement often alleviates IBS symptoms. Sixth, intractable IBS patients have often experienced traumatic life events [12]. Improved brain function has been reported after treatment including psychotherapy [13]. Seventh, the effects of health beliefs and learned behaviors may adversely affect outcome.

There is evidence from a systematic review and meta-analysis of rigorously executed trials on IBS that psychological treatment in general is effective for IBS [14]. Hypnotherapy is a representative strategy for refractory IBS [15]. Autogenic training is auto-hypnosis with the goal of being able to self-administer suggestions of relaxation. We reported that autogenic training is effective for intractable IBS patients [16]. Cognitive-behavioral therapy (CBT) focuses on ways to increase or decrease a particular behavior that addresses automatic thoughts and irrational beliefs. CBT was found to be more effective than an educational intervention [17]. Psychological treatments are interpreted as how humans have been influenced by others. During psychological treatments, function of the specific brain regions in patients is altered. Good examples are the decreased activities of the anterior cingulate cortex during hypnotic modulation of pain [18] and the increased activities of the anterior cingulate cortex during empathy to pain [19]. Therefore, how neural processing of interoception is modified after the activation of specific brain regions, including the mirror neuron system, should be explored. Further research on neurological approaches to biopsychosocial medicine will be valuable.

Abbreviations

IBS: irritable bowel syndrome; CBT: cognitive-behavioral therapy

Competing interests

The authors declare that they have no competing interests.

Acknowledgements

This research was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, and Culture of Japan, and a Grant-in-Aid for Scientific Research from the Ministry of Health, Welfare, and Labor of Japan.

References

  1. Drossman DA: The functional gastrointestinal disorders and the Rome III process.

    Gastroenterology 2006, 130:1377-90. PubMed Abstract | Publisher Full Text OpenURL

  2. Fukudo S, Kanazawa M, Mizuno T, Hamaguchi T, Kano M, Watanabe S, Sagami Y, Shoji T, Endo Y, Hongo M, Itoyama Y, Yanai K, Tashiro M, Aoki M: Impact of serotonin transporter gene polymorphism on brain activation by colorectal distention.

    Neuroimage 2009, 47:946-951. PubMed Abstract | Publisher Full Text OpenURL

  3. Fukudo S: Role of corticotropin-releasing hormone in irritable bowel syndrome and intestinal inflammation.

    J Gastroenterol 2007, 42(Suppl 17):48-51. PubMed Abstract | Publisher Full Text OpenURL

  4. Fukudo S, Nomura T, Muranaka M, Taguchi F: Brain-gut response to stress and cholinergic stimulation in irritable bowel syndrome.

    J Clin Gastroenterol 1993, 17:133-141. PubMed Abstract | Publisher Full Text OpenURL

  5. Silverman DHS, Munakata JA, Ennes H, Mandelkern MA, Hoh CK, Mayer EA: Regional cerebral activity in normal and pathological perception of visceral pain.

    Gastroenterology 1997, 112:64-72. PubMed Abstract | Publisher Full Text OpenURL

  6. Mertz H, Morgan V, Tanner G, Pickens D, Price R, Shyr Y, Kessler R: Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention.

    Gastroenterology 2000, 118:842-8. PubMed Abstract | Publisher Full Text OpenURL

  7. Shinozaki M, Fukudo S, Hongo M, Shimosegawa T, Sasaki D, Matsueda K, Harasawa S, Miura S, Mine T, Kaneko H, Arakawa T, Haruma K, Torii A, Azuma T, Miwa H, Fukunaga M, Handa M, Kitamori S, Miwa T, IBS Club: High Prevalence of Irritable Bowel Syndrome in Medical Outpatients in Japan.

    J Clin Gastroenterol 2008, 42:1010-1016. PubMed Abstract | Publisher Full Text OpenURL

  8. Owens DM, Nelson DK, Talley NJ: The irritable bowel syndrome: Long term prognosisand the physician-patient interaction.

    Ann Intern Med 1995, 122:107-112. PubMed Abstract | Publisher Full Text OpenURL

  9. Whitehead WE, Crowell MD, Robinson JC, Heller BR, Schuster MM: Effects of stressful life events on bowel symptoms: subjects with irritable bowel syndrome compared with subjects without bowel dysfunction.

    Gut 1992, 33:825-830. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  10. Spiller RC: Problems and challenges in the design of irritable bowel syndrome clinical trials: experience from published trials.

    Am J Med 1999, 107(5A):91S-97S. PubMed Abstract | Publisher Full Text OpenURL

  11. Kanazawa M, Endo Y, Whitehead WE, Kano M, Hongo M, Fukudo S: Patients and nonconsulters with irritable bowel syndrome reporting a parental history of bowel problems have more impaired psychological distress.

    Dig Dis Sci 2004, 49:1046-53. PubMed Abstract | Publisher Full Text OpenURL

  12. Drossman DA, Leserman J, Nachman G, Li Z, Gluck H, Toomey TC, Mitchell CM: Sexual and physical abuse in women with functional or organic gastrointestinal disorders.

    Ann Intern Med 1990, 113:828-833. PubMed Abstract OpenURL

  13. Drossman DA, Ringel Y, Vogt B, Leserman J, Lin W, Smith JK, Whitehead WE: Alterations of brain activity associated with resolution of emotional distress and pain in a case of severe IBS.

    Gastroenterology 2003, 124:754-761. PubMed Abstract | Publisher Full Text OpenURL

  14. Zijdenbos IL, de Wit NJ, van der Heijden GJ, Rubin G, Quartero AO: Psychological treatments for the management of irritable bowel syndrome.

    Cochrane Database Syst Rev 2009, (1):CD006442. PubMed Abstract | Publisher Full Text OpenURL

  15. Whorwell PJ, Prior A, Faragher EB: Controlled trial of hypnotherapy in the treatment of severe refractory irritable bowel syndrome.

    Lancet 1984, 2:1232-1233. PubMed Abstract | Publisher Full Text OpenURL

  16. Shinozaki M, Kanazawa M, Kano M, Endo Y, Nakaya N, Hongo M, Fukudo S: Effect of autogenic training on general improvement in patients with irritable bowel syndrome: a randomized controlled trial.

    Appl Psychophysiol Biofeedback 2010, 35:189-198. PubMed Abstract | Publisher Full Text OpenURL

  17. Drossman DA, Toner BB, Whitehead WE, Diamant NE, Dalton CB, Duncan S, Emmott S, Proffitt V, Akman D, Frusciante K, Le T, Meyer K, Bradshaw B, Mikula K, Morris CB, Blackman CJ, Hu Y, Jia H, Li Z, Koch GG, Bangdiwala SI: Cognitive-behavioral therapy vs. education and desipramine vs. placebo for moderate to severe functional bowel disorders.

    Gastroenterology 2003, 125:19-31. PubMed Abstract | Publisher Full Text OpenURL

  18. Rainville P, Duncan GH, Price DD, Carrier B, Bushnell MC: Pain affect encoded in human anterior cingulate but not somatosensory cortex.

    Science 1997, 277:968-71. PubMed Abstract | Publisher Full Text OpenURL

  19. Singer T, Seymour B, O'Doherty J, Kaube H, Dolan RJ, Frith CD: Empathy for pain involves the affective but not sensory components of pain.

    Science 2004, 303:1157-62. PubMed Abstract | Publisher Full Text OpenURL